Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-28 4:50 pm Purchase |
2025-03-26 | 13D | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 15,623,659 49.900% |
1,293,722 (+9.03%) |
Filing History |
| 2025-02-14 12:37 pm Sale |
2024-12-31 | 13G | Benitec Biopharma Inc. BNTC |
JANUS HENDERSON GROUP PLC JHG |
2,616,427 11.300% |
-75,983 (-2.82%) |
Filing History |
| 2025-02-13 4:15 pm Unchanged |
2024-12-31 | 13G | Benitec Biopharma Inc. BNTC |
HBM BIOVENTURES CAYMAN LTD | 1,041,669 4.500% |
0 (Unchanged) |
Filing History |
| 2025-01-27 12:51 pm Purchase |
2024-12-31 | 13G | Benitec Biopharma Inc. BNTC |
FRANKLIN RESOURCES INC BEN |
4,493,691 18.100% |
239 (+0.01%) |
Filing History |
| 2024-12-06 1:47 pm Purchase |
2024-11-29 | 13G | Benitec Biopharma Inc. BNTC |
JANUS HENDERSON GROUP PLC JHG |
2,692,410 11.600% |
1,815,887 (+207.17%) |
Filing History |
| 2024-11-18 4:36 pm Purchase |
2024-11-14 | 13D | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 14,329,937 49.900% |
5,500,884 (+62.30%) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Benitec Biopharma Inc. BNTC |
Nantahala Capital Management, LLC | 1,038,371 9.654% |
1,038,371 (New Position) |
Filing History |
| 2024-11-14 1:37 pm Sale |
2024-09-30 | 13G | Benitec Biopharma Inc. BNTC |
JANUS HENDERSON GROUP PLC JHG |
876,523 8.300% |
-1,805,752 (-67.32%) |
Filing History |
| 2024-11-13 4:18 pm Purchase |
2024-09-30 | 13G | Benitec Biopharma Inc. BNTC |
HBM BIOVENTURES CAYMAN LTD | 1,041,669 9.700% |
191,776 (+22.56%) |
Filing History |
| 2024-11-07 12:30 pm Purchase |
2024-09-30 | 13G | Benitec Biopharma Inc. BNTC |
FRANKLIN RESOURCES INC BEN |
4,493,452 15.100% |
3,905,215 (+663.88%) |
Filing History |
| 2024-11-06 3:26 pm Unchanged |
2024-10-31 | 13G | Benitec Biopharma Inc. BNTC |
JANUS HENDERSON GROUP PLC JHG |
2,682,275 13.500% |
0 (Unchanged) |
Filing History |
| 2024-10-25 2:19 pm Purchase |
2024-10-21 | 13G | Benitec Biopharma Inc. BNTC |
JANUS HENDERSON GROUP PLC JHG |
2,682,275 13.500% |
2,501,876 (+1386.86%) |
Filing History |
| 2024-09-30 5:18 pm Purchase |
2024-09-26 | 13D | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 8,829,053 49.900% |
7,128,203 (+419.10%) |
Filing History |
| 2024-04-29 4:08 pm Purchase |
2024-04-22 | 13D | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,700,850 19.990% |
1,438,007 (+547.10%) |
Filing History |
| 2024-04-29 4:05 pm Purchase |
2024-04-17 | 13G | Benitec Biopharma Inc. BNTC |
HBM BIOVENTURES CAYMAN LTD | 849,893 9.990% |
849,893 (New Position) |
Filing History |
| 2024-04-29 11:44 am Purchase |
2024-04-22 | 13G | Benitec Biopharma Inc. BNTC |
Steven Michael Oliveira | 791,235 8.890% |
693,032 (+705.71%) |
Filing History |
| 2024-04-11 12:10 pm Purchase |
2023-08-11 | 13G | Benitec Biopharma Inc. BNTC |
ADAGE CAPITAL PARTNERS GP LLC | 264,510 9.990% |
75,322 (+39.81%) |
Filing History |
| 2024-02-14 6:18 pm Sale |
2023-12-31 | 13G | Benitec Biopharma Inc. BNTC |
Citadel Advisors LLC | 95,356 3.600% |
-84,674 (-47.03%) |
Filing History |
| 2024-02-14 10:00 am Sale |
2023-12-31 | 13G | Benitec Biopharma Inc. BNTC |
JANUS HENDERSON GROUP PLC JHG |
180,399 7.000% |
-25,771 (-12.50%) |
Filing History |
| 2024-02-13 5:16 pm Purchase |
2023-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 262,843 9.990% |
262,843 (New Position) |
Filing History |